| Primary |
| Poisoning |
16.7% |
| Product Used For Unknown Indication |
16.7% |
| Chemical Poisoning |
11.1% |
| Prophylaxis |
11.1% |
| Vitamin B12 Deficiency |
11.1% |
| Anaphylactic Shock |
5.6% |
| Blood Cyanide Increased |
5.6% |
| Carbon Monoxide Poisoning |
5.6% |
| Gas Poisoning |
5.6% |
| Toxicity To Various Agents |
5.6% |
| Type 2 Diabetes Mellitus |
5.6% |
|
| Anaphylactic Reaction |
5.0% |
| Anaphylactic Shock |
5.0% |
| Blood Cyanide Increased |
5.0% |
| Carboxyhaemoglobin Normal |
5.0% |
| Cerebral Haematoma |
5.0% |
| Cerebrovascular Accident |
5.0% |
| Death |
5.0% |
| Device Alarm Issue |
5.0% |
| False Positive Investigation Result |
5.0% |
| Haemodialysis Complication |
5.0% |
| Haemoglobin Decreased |
5.0% |
| Hypersensitivity |
5.0% |
| Off Label Use |
5.0% |
| Pancreatitis |
5.0% |
| Resuscitation |
5.0% |
| Shock |
5.0% |
| Subdural Haematoma |
5.0% |
| Syncope |
5.0% |
| Treatment Failure |
5.0% |
| Viral Test Positive |
5.0% |
|
| Secondary |
| Pain |
23.0% |
| Vitamin B12 Deficiency |
12.3% |
| Pregnancy |
11.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
11.2% |
| Drug Exposure During Pregnancy |
8.0% |
| Anaemia |
4.3% |
| Drug Use For Unknown Indication |
4.3% |
| Asthma |
3.2% |
| Blood Cholesterol Increased |
3.2% |
| Foetal Exposure During Pregnancy |
2.7% |
| Hypertension |
2.7% |
| Prophylaxis |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Homocystinuria |
1.6% |
| Product Used For Unknown Indication |
1.6% |
| Analgesia |
1.1% |
| Bipolar Disorder |
1.1% |
| Gastrointestinal Ulcer |
1.1% |
| Medical Diet |
1.1% |
| Vitamin Supplementation |
1.1% |
|
| Pelvic Deformity |
18.2% |
| Drug Exposure During Pregnancy |
13.6% |
| Pelvic Pain |
13.6% |
| Idiopathic Pulmonary Fibrosis |
11.4% |
| Hip Dysplasia |
9.1% |
| Pregnancy |
6.8% |
| Forceps Delivery |
4.5% |
| Maternal Drugs Affecting Foetus |
4.5% |
| Breast Cancer Female |
2.3% |
| Congenital Hip Deformity |
2.3% |
| Foetal Exposure During Pregnancy |
2.3% |
| Headache |
2.3% |
| Maternal Exposure During Pregnancy |
2.3% |
| Neonatal Infection |
2.3% |
| Pancreatitis Acute |
2.3% |
| Rhabdomyolysis |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
49.4% |
| Drug Use For Unknown Indication |
11.4% |
| Crohn's Disease |
7.0% |
| Pain |
5.1% |
| Prophylaxis |
4.2% |
| Hypertension |
3.1% |
| Vitamin B12 Deficiency |
3.1% |
| Rheumatoid Arthritis |
3.0% |
| Depression |
1.9% |
| Vitamin Supplementation |
1.6% |
| Anaemia |
1.3% |
| Cardiac Failure |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Constipation |
1.1% |
| Multiple Myeloma |
1.1% |
| Atrial Fibrillation |
1.0% |
| Diabetes Mellitus |
0.9% |
| Tuberculosis |
0.9% |
| Breast Cancer |
0.8% |
| Diarrhoea |
0.8% |
|
| Contusion |
11.7% |
| Restlessness |
8.6% |
| Nausea |
8.0% |
| Vomiting |
7.4% |
| White Blood Cell Count Increased |
6.8% |
| Weight Decreased |
6.2% |
| International Normalised Ratio Increased |
4.3% |
| Pain |
4.3% |
| Pulmonary Embolism |
4.3% |
| Hyponatraemia |
3.7% |
| Lower Respiratory Tract Infection |
3.7% |
| Malaise |
3.7% |
| Sepsis |
3.7% |
| Swelling Face |
3.7% |
| Swollen Tongue |
3.7% |
| Urinary Tract Infection |
3.7% |
| Dyspnoea |
3.1% |
| Interstitial Lung Disease |
3.1% |
| Liver Function Test Abnormal |
3.1% |
| Mobility Decreased |
3.1% |
|
| Interacting |
| Non-small Cell Lung Cancer |
50.0% |
| Vitamin Supplementation |
50.0% |
|
| Malignant Neoplasm Progression |
100.0% |
|
